|
|
|
|
ConsulTech GmbH
|
|
ConsulTech GmbH
|
|
ConsulTech is a consulting company founded in 1992. Since then, we have been supporting biotech-nology, pharmaceutical and medical technology companies as well as research institutions with the entire process of setting-up and executing proposals for R&D projects. In projects funded by the European Commission, ConsulTech supports the coordinator by resuming administrative tasks allow-ing coordinators and partners to fully concentrate on the scientific and technical success of the pro-ject. We solve financial and administrative issues, organise meetings, take care of the timely delivery of milestones and reports and much more.
|
|
|
|
|
|
|
|
 |
News and Press Releases |
 |
Merck to Provide BioReliance® End-to-End Solutions to Phanes Therapeutics
• Collaboration to accelerate development and manufacturing of Bispecific Antibody
• Merck plans to offer Phanes a full suite of products and services under its BioReliance® offering
More info >> |
|
 |
White Papers |
 |
|
The Promise and Challenge of Adaptive Design in Oncology Trials
Medpace
Clinical oncology trials are more complex and time consuming than those
in any other therapeutic area and failure rates are frustratingly high.
Given the urgent need for new oncologic therapies, sponsors are eager to
find more effective ways to conduct clinical research.
Incorporating adaptive design methodologies into clinical trials can
reduce costs and enhance efficiency while maintaining trial integrity.
They can also reduce the number of patients on placebo and
sub-therapeutic doses. In light of this promise, regulatory bodies have
created guidelines supportive of adaptive design.
More info >> |
|
 |
Industry Events |
 |
INTERPHEX 2020
15-17 July 2020, Javits Center NYC
More info >> |
|
|
|
